Clinical and biochemical characterization of women having Polycystic Ovary Syndrome
DOI:
https://doi.org/10.18597/rcog.534Keywords:
polycystic ovary syndrome, hirsutism, hyperandrogenismAbstract
Polycystic Ovary Syndrome (PCOS) has 4%-8% prevalence in young people. Diagnosis is based on two out of the following three criteria: oligoanovulation, clinical or biochemical hyperandrogenism and polycystic morphology using ultrasound. It is necessary to rule out other hyperandrogenic entities like congenital adrenal hyperplasia, Cushing’s disease and androgen-producing tumors. PCOS patients have a high risk of carbohydrate intolerance, diabetes and metabolic syndrome, but there is no strong medical evidence to support greater ischemic myocardial events or endometrial cancer frequency in such patients.Author Biographies
Carlos Alfonso Builes
Ivonne Díaz
Jimmy Castañeda
Luis Ernesto Pérez
References
Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181-91.
Knochenhauer ES, Key TJ, Hahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-82.
Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin Endocrinol Metab 2000;85:2434-8.
Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Endocrinol Metab 2004;89:2745-9.
Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol. (oxf) 1999;51:779-86.
Saleh AM, Khalil HS. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 2004;83:614-21.
Rotterdam ESHRE / ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
Malcolm CE, Cumming DC. Does anovulation exist in eumenorrheic women?. Obstet Gynecol 2003;102:317-8.
Wild R, Vesely S, Beebe L, Whitsett T, Owen W. Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome. J. Clin Endocrinol Metab 2005;90:4112-4.
Ehrman D. Polycystic ovary syndrome. N Engl J Med 2005;352:1223-36.
Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries-- a common finding in normal women. Lancet 1988;1:870-2.
Adams J, Taylor A, Crowley WF Jr, Hall JE. Polycystic ovarian morphology with regular ovulatory cycles insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab 2004;89:4343-50.
Jonard S, Robert Y, Cardet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod 2003;18:598-603.
Dewailly D. Nonclassic 21-hidroxilase deficiency. Semin Reprod Med 2002;20:243-8.
Moran C, Azziz R. 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender. Semin Reprod Med 2003;21:295-300.
Raff H, Findling JW. A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 2003;138:980-91.
Growth Hormone Society: Pituitary Society. Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society. J Clin Endocrinol Metab 2004;89:3099-102.
Pérez LE. Síndrome de Ovario poliquístico. Patologías asociadas a hirsutismo. En: Pérez LE. Infertilidad y Endocrinología Reproductiva. 2a. ed. Bogotá, Colombia: Imprenta Hospital Militar; 2000. p. 152-61.
Schlechte J. Clinical practice. Prolactinoma. N Engl J Med 2003;349:2035-41.
Bayrak A, Saadat P, Mor E, Chong R, Paulson RJ, Sokol RZ. Pituitary imaging is indicated for the evaluation of hyperprolactinemia. Fertil Steril 2005;84:181-5.
Kalro BN. Impaired fertility caused by endocrine dysfunction in women. Endocrinol Metab Clin North Am 2003;32:573-92.
García J, Polanía D, Builes CA. Hiperplasia hipofisiaria secundaria a hipotiroidismo primario. Acta Med Colomb 2005;30:65-7.
Ozbey N, Sariyildiz E, Yilmaz L, Orthan Y, Sencer E, Molvalilar S. Primary hypothyroidism with hyperprolactinaemia and pituitary enlargement mimicking a pituitary macroadenoma. Int J Clin Pract 1997;51:409-11.
Nelson LM, Covington SN, Rebar RW. An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril 2005;83:1327-32.
Padrón R, Sell J, Montejo L. Búsqueda de trastornos endocrinos en pacientes con falla ovárica prematura. Rev Cubana Endocrinol 2001;12:144-9.
The IDF consensus world wide definition of metabolic syndrome. 2005. http://www.IDF.org
Chang RJ. A practical approach to the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol 2004;191:713-7.
Isojarvi JL, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla VV. Polycystic ovaries and hyperandrogenism in women taking valproato for epilepsy. N Engl J Med 1993;329:1383-8.
Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2694-8.
Norman RJ, Wu R, Stankiewicz M. Polycystic ovary syndrome. Med J Aust 2004;180:132-7.
Ibanez L, Polau N, de Zegher F. Ovarian hyperresponsiveness to follicle stimulating hormone in adolescent girl born small for gestational age. J Clin Endocrinol Metab 2000;85:2624-6.
Colilla S, Cox NJ, Ehrmann DA. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab 2001;86:2027-31.
Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165-9.
Dunaif A, Segal KR, Futter weit W, Dobrjaosky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38:1165-74.
Apridonidze T, Essah P, Inorno M,. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929-35.
Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long term follow up: a retrospective cohort study. Clin Endocrinol (Oxf) 2000;52:595-600.
Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003;361:1810-2.
How to Cite
Downloads
Downloads
Published
Issue
Section
Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |